BSECompany Update4h ago · 25 Sept 2026, 02:05 pm

Clarification with respect to Volume Movement

Caplin Point Laboratories Ltd · 524742

✦ AI SummaryRegulatory

Caplin Point Laboratories Ltd issued a clarification regarding a significant increase in trading volume of its equity shares across exchanges, stating that the company has made all requisite disclosures and the increase is purely market-driven.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Caplin Point Laboratories Ltd - 524742 - Clarification With Respect To Volume Movement

Attachments (1)

📄

3dc8f528-2cf9-42e2-bd47-bbc301a53165.pdf

pdf

Download →
View document text
September 25, 2026 BSE Limited National Stock Exchange of India Ltd., Department of Corporate Relationship Department of Corporate Services 1st Floor, New Trade Ring, Rotunda Building Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers C-1, Block G,Bandra Kurla Complex, Dalal Street, Mumbai- 400001 Bandra (E), Mumbai – 400 051 Scrip Code: 524742 S c r i p C o d e : C A P L I P O I N T . Dear Sir/Madam, Sub: Clarification with respect to Volume Movement- BSE email dated September 25, 2026 We refer to the captioned email received from BSE Limited ("BSE") on September 25, 2026, regarding a significant increase in the trading volume of the equity shares of Caplin Point Laboratories Limited ("the Company") across exchanges in the recent past. We would like to inform you that the company has duly made all requisite disclosures in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations"), including all material events and price sensitive information having a bearing on the operations/performance of the Company. The Company confirms that it has not withheld any material/price sensitive information that in its opinion would have bearing on the volume/price behaviour of the shares. Accordingly, the said increase in trading volume of shares of the Company is purely market driven and the Company is not aware of any specific reasons contributing to the same. The Company further confirms its continued commitment to comply with all applicable disclosure requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time. This is for your kind information and records. Kindly acknowledge the receipt. Thanking You, Sincerely yours, For Caplin Point Laboratories Limited Venkatram G General Counsel & Company Secretary Membership No A23989